Acromegaly clinical trials at University of California Health
3 in progress, 0 open to eligible people
Long-Term Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Advance)
Sorry, in progress, not accepting new patients
A phase 2, open label, long-term extension study designed to evaluate the safety and efficacy of paltusotine (formerly CRN00808; an oral selective nonpeptide somatostatin receptor type 2 biased agonist) in subjects with acromegaly.
at UCLA
Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
Sorry, in progress, not accepting new patients
The purpose of this trial is to assess the long-term safety and efficacy of CAM2029 in patients with acromegaly. Patients will be administered CAM2029 subcutaneously once monthly during 12 months. Patients fulfilling trial NCT04076462 will be…
at UCLA
Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Sorry, not accepting new patients
The present study is planned as an expanded treatment protocol to provide acromegalic patients for whom medical therapy is appropriate access to pasireotide LAR while regulatory approval for pasireotide is sought.
at UCLA
Last updated: